CRMD CORMEDIX INC US FDA Inspections 8-K Filing 2023 - Other Events CorMedix Inc. announced that the resubmission of the New Drug Application for DefenCath has been accepted for filing by the FDA with a target action date of November 15, 2023.Get access to all SEC 8-K filings of the CORMEDIX INC